Received:28 October 2019,
Published:30 March 2020
移动端阅览
Shuang YOU, Shuaibin LIU, Xiaolan OUYANG, et al. Therapeutic effect of collagen on vaginal atrophy in ovariectomized rats[J]. Journal of Third Military Medical University, 2020, 42(6): 632-638,封三.
Shuang YOU, Shuaibin LIU, Xiaolan OUYANG, et al. Therapeutic effect of collagen on vaginal atrophy in ovariectomized rats[J]. Journal of Third Military Medical University, 2020, 42(6): 632-638,封三. DOI: 10.16016/j.1000-5404.201910187.
Objective
2
To evaluate the therapeutic effect of collagen on vaginal atrophy (VA) in ovariectomized rats.
Methods
2
Forty female SD rats were randomized into sham-operated group
VA model group
collagen group and estrogen group (
n
=10). In the latter 3 groups
rat models of VA were established by ovariectomy and treated with collagen or estrogen for 14 consecutive days starting from the 4th week after the operation. Body weight and vaginal pH ualue of the rats were measured daily
and the vaginal tissues were sampled after the treatments to examine the expression levels of PCNA
MMP-1
TIMP-1
COL-Ⅰ
COL-Ⅲ and TGF-β1 using immunohistochemistry; the mRNA expression levels of MMP-1
TIMP-1
COL-Ⅰ
COL-Ⅲ
and TGF-β1 were detected using real-time PCR. Western blotting was used to detect the protein levels of TGF-β1
Smad2/3 and p-Smad2/3 in the vaginal tissues.
Results
2
The vaginal pH ualue of the ovariectomized rats decreased obviously after collagen treatment
which significantly increased the thickness and proliferative activity of the vaginal epithelium
enhanced the synthesis and lowered the degradation of extracellular matrix components
and obviously increased the expression of phosphorylated Smad2/3 protein in the vaginal tissues. Compared with estrogen treatment
collagen showed less adverse effects on the uterus.
Conclusion
2
Collagen can effectively alleviate vaginal atrophy
increase extracellular matrix components in the vaginal tissue and promote the repair of vaginal epithelium in ovariectomized rats.
SUCKLING J1 LETHABY A KENNEDY R Local oestrogen for vaginal atrophy in postmenopausal women Cochrane Database Syst Rev 2003 4 CD001500 10.1002/14651858.CD001500 SUCKLING J1, LETHABY A, KENNEDY R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev, 2003; (4): CD001500. DOI: 10.1002/14651858.CD001500.
CARMIGNANI L O PEDRO A O MONTEMOR E B Effects of a soy-based dietary supplement compared with low-dose hormone therapy on the urogenital system: a randomized, double-blind, controlled clinical trial Menopause 2015 22 7 741 749 10.1097/GME.0000000000000380 CARMIGNANI L O, PEDRO A O, MONTEMOR E B, et al . Effects of a soy-based dietary supplement compared with low-dose hormone therapy on the urogenital system: a randomized, double-blind, controlled clinical trial. Menopause, 2015, 22(7): 741-749. DOI: 10.1097/GME.000000000 0000380.
SOCIETY OF OBSTETRICIANS AND GYNAECOLOGISTS OF CANADA SOGC clinical practice guidelines. The detection and management of vaginal atrophy. Number 145, May 2004 Int J Gynaecol Obstet 2005 88 2 222 228 10.1016/j.ijgo.2004.11.003 SOCIETY OF OBSTETRICIANS AND GYNAECOLOGISTS OF CANADA.SOGC clinical practice guidelines. The detection and management of vaginal atrophy. Number 145, May 2004. Int J Gynaecol Obstet, 2005, 88(2): 222-228. DOI: 10.1016/j.ijgo.2004.11.003.
PORTMAN D J GASS M L VULVOVAGINAL ATROPHY TERMINOLOGY CONSENSUS CONFERENCE PANEL Genitourinary syndrome of menopause: new terminology forvulvovaginal atrophy from the international society for the study of women's sexual health and the North American menopause society Maturitas 2014 79 3 349 354 10.1016/j.maturitas.2014.07.013 PORTMAN D J, GASS M L, VULVOVAGINAL ATROPHY TERMINOLOGY CONSENSUS CONFERENCE PANEL. Genitourinary syndrome of menopause: new terminology forvulvovaginal atrophy from the international society for the study of women's sexual health and the North American menopause society. Maturitas, 2014, 79(3): 349-354. DOI: 10.1016/j.maturitas.2014.07.013.
WILLS S RAVIPATI A VENUTURUMILLI P Effects of vaginal estrogens on serum estradiol levels in postmenopausal breast cancer survivors and women at risk of breast cancer taking an aromatase inhibitor or a selective estrogen receptormodulator J Oncol Pract 2012 8 3 144 148 10.1200/JOP.2011.000352 WILLS S, RAVIPATI A, VENUTURUMILLI P, et al . Effects of vaginal estrogens on serum estradiol levels in postmenopausal breast cancer survivors and women at risk of breast cancer taking an aromatase inhibitor or a selective estrogen receptormodulator. J Oncol Pract, 2012, 8(3): 144-148. DOI:10.1200/JOP.2011.000352.
The 2017 hormone therapy position statement of the North American menopausesociety . Menopause , 2018 , 25 ( 11 ): 1362 - 1387 . DOI: 10.1097/GME.0000000000001241 . The 2017 hormone therapy position statement of the North American menopausesociety. Menopause, 2018, 25(11): 1362-1387. DOI: 10.1097/GME.0000000000001241.
SORUSHANOVA A DELGADO L M WU Z N The collagensuprafamily: from biosynthesis to advanced biomaterial development Adv Mater Weinheim 2019 31 1 e1801651 10.1002/adma.201801651 SORUSHANOVA A, DELGADO L M, WU Z N, et al . The collagensuprafamily: from biosynthesis to advanced biomaterial development. Adv Mater Weinheim, 2019, 31(1): e1801651. DOI: 10.1002/adma.201801651.
SHOULDERS M D RAINES R T Collagen structure andstability Annu Rev Biochem 2009 78 929 958 10.1146/annurev.biochem.77.032207.120833 SHOULDERS M D, RAINES R T. Collagen structure andstability. Annu Rev Biochem, 2009, 78: 929-958. DOI: 10.1146/annurev.biochem.77.032207.120833.
RICARD-BLUM S The collagenfamily Cold Spring Harb Perspect Biol 2011 3 1 a004978 10.1101/cshperspect.a004978 RICARD-BLUM S. The collagenfamily. Cold Spring Harb Perspect Biol, 2011, 3(1): a004978. DOI: 10.1101/cshperspect.a004978.
CASTELO-BRANCO C CANCELO M J VILLERO J Management of post-menopausal vaginal atrophy and atrophic vaginitis Maturitas 2005 52 Suppl 1 S46 S52 10.1016/j.maturitas.2005.06.014 CASTELO-BRANCO C, CANCELO M J, VILLERO J, et al . Management of post-menopausal vaginal atrophy and atrophic vaginitis.Maturitas, 2005, 52(Suppl 1): S46-S52. DOI:10.1016/j.maturitas.2005.06.014.
ROBERTS A B MCCUNE B K SPORN M B TGF-beta: regulation of extracellularmatrix Kidney Int 1992 41 3 557 559 10.1038/ki.1992.81 ROBERTS A B, MCCUNE B K, SPORN M B. TGF-beta: regulation of extracellularmatrix. Kidney Int, 1992, 41(3): 557-559. DOI: 10.1038/ki.1992.81.
DERYNCK R ZHANG Y G Smad-dependent and Smad-independent pathways in TGF-beta family signalling Nature 2003 425 6958 577 584 10.1038/nature02006 DERYNCK R, ZHANG Y G.Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature, 2003, 425(6958): 577-584. DOI: 10.1038/nature02006.
SHI Y G MASSAGUÉ J Mechanisms of TGF-β signaling from cell membrane to thenucleus Cell 2003 113 6 685 700 10.1016/s0092-8674(03)00432-x SHI Y G, MASSAGUÉ J. Mechanisms of TGF-β signaling from cell membrane to thenucleus. Cell, 2003, 113(6): 685-700. DOI: 10.1016/s0092-8674(03)00432-x.
STURDEE D W PANAY N INTERNATIONAL MENOPAUSE SOCIETY WRITING GROUP Recommendations for the management of postmenopausal vaginalatrophy Climacteric 2010 13 6 509 522 10.3109/13697137.2010.522875 STURDEE D W, PANAY N, INTERNATIONAL MENOPAUSE SOCIETY WRITING GROUP. Recommendations for the management of postmenopausal vaginalatrophy. Climacteric, 2010, 13(6): 509-522. DOI: 10.3109/13697137.2010.522875.
North American Menopause Society The 2012 hormone therapy position statement of: The North American Menopause Society Menopause 2012 19 3 257 271 10.1097/gme.0b013e31824b970a North American Menopause Society. The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause, 2012, 19(3): 257-271. DOI: 10.1097/gme.0b013e31824b970a.
ARCHER D F Efficacy and tolerability of local estrogen therapy for urogenitalatrophy Menopause 2010 17 1 194 203 10.1097/gme.0b013e3181a95581 ARCHER D F. Efficacy and tolerability of local estrogen therapy for urogenitalatrophy. Menopause, 2010, 17(1): 194-203. DOI: 10.1097/gme.0b013e3181a95581.
NELSON H D HANEY E HUMPHREY L Management of menopause-relatedsymptoms Evid Rep Technol Assess (Summ) 2005 120 1 6 NELSON H D, HANEY E, HUMPHREY L, et al . Management of menopause-relatedsymptoms. Evid Rep Technol Assess (Summ), 2005(120): 1-6.
JIN J Vaginal and urinary symptoms ofmenopause JAMA 2017 317 13 1388 10.1001/jama.2017.0833 JIN J. Vaginal and urinary symptoms ofmenopause. JAMA, 2017, 317(13): 1388. DOI:10.1001/jama.2017.0833.
MANSON J E KAUNITZ A M Menopause management: getting clinical care back ontrack N Engl J Med 2016 374 9 803 806 10.1056/NEJMp1514242 MANSON J E, KAUNITZ A M. Menopause management: getting clinical care back ontrack. N Engl J Med, 2016, 374(9): 803-806. DOI: 10.1056/NEJMp1514242.
BEDELL S NACHTIGALL M NAFTOLIN F The pros and cons of plant estrogens formenopause J Steroid Biochem Mol Biol 2014 139 225 236 10.1016/j.jsbmb.2012.12.004 BEDELL S, NACHTIGALL M, NAFTOLIN F. The pros and cons of plant estrogens formenopause. J Steroid Biochem Mol Biol, 2014, 139: 225-236. DOI: 10.1016/j.jsbmb.2012.12.004.
GORDON M K HAHN R A Collagens Cell Tissue Res 2010 339 1 247 257 10.1007/s00441-009-0844-4 GORDON M K, HAHN R A.Collagens. Cell Tissue Res, 2010, 339(1): 247-257. DOI: 10.1007/s00441-009-0844-4.
WONG M Y HARMANLI O H AGAR M Collagen content of nonsupport tissue in pelvic organ prolapse and stress urinaryincontinence Am J Obstet Gynecol 2003 189 6 1597 1599 10.1016/j.ajog.2003.09.043 WONG M Y, HARMANLI O H, AGAR M, et al . Collagen content of nonsupport tissue in pelvic organ prolapse and stress urinaryincontinence. Am J Obstet Gynecol, 2003, 189(6): 1597-1599; discussion 1599-1600. DOI: 10.1016/j.ajog.2003.09.043.
HAN L Y WANG L WANG Q Association between pelvic organ prolapse and stress urinary incontinence withcollagen Exp Ther Med 2014 7 5 1337 1341 10.3892/etm.2014.1563 HAN L Y, WANG L, WANG Q, et al . Association between pelvic organ prolapse and stress urinary incontinence withcollagen. Exp Ther Med, 2014, 7(5): 1337-1341. DOI: 10.3892/etm.2014.1563.
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
